CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract

European Journal of Nutrition

Volumn 51, Issue 4, 2012, Pages 465-476

  Oleaga, Carlota ^a   García, Miriam ^a   Solé, Anna ^a   Ciudad, Carlos J ^a   Izquierdo Pulido, Maria ^a   Noé, Véronique ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

AhR; Breast cancer; Cocoa; CYP1A1; ER ; Tamoxifen

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; COCOA EXTRACT; CYTOCHROME P450 1A1; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; POLYPHENOL; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CACAO; CANCER CELL CULTURE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; PROMOTER REGION; PROTEIN ANALYSIS; RECEPTOR BINDING; TRANSCRIPTION INITIATION;

THEOBROMA CACAO;

EID: 84864676908     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-011-0231-2     Document Type: Article

References (60)

1. Ferlay J, Bray F, Pisani P et al (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer-Base no. 5, Version 2.0. International Agency for Research on Cancer, Lyon
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592 (Pubitemid 46359643)
3. Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344:276-285 (Pubitemid 32108534)
4. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616 (Pubitemid 34498648)
5. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 100:3913-3918 (Pubitemid 36418131)
6. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-282
7. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766:63-78 (Pubitemid 44175632)
8. Cavalieri EL, Rogan EG (2004) A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci 1028:247-257 (Pubitemid 40361826)
9. Patel MM, Bhat HK (2004) Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: involvement of metabolic activation and cytochrome P450. J Biochem Mol Toxicol 18:37-42 (Pubitemid 38312721)
10. Dhingra K (1999) Antiestrogens-tamoxifen, SERMs and beyond. Invest New Drugs 17:285-311
11. Rutqvist LE, Cedermark B, Fornander T, Glas U, Johansson H, Nordenskjold B, Rotstein S, Skoog L, Somell A, Theve T (1989) The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer. J Clin Oncol 7:1474-1484 (Pubitemid 19245118)
12. Port ER, Montgomery LL, Heerdt AS, Borgen PI (2001) Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol 7:580-585 (Pubitemid 32735038)
13. Ahmad N, Mukhtar H (1999) Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 57:78-83 (Pubitemid 29176620)
14. Kavanagh KT, Hafer LJ, Kim DW, Mann KK, Sherr DH, Rogers AE, Sonenshein GE (2001) Green tea extracts decrease carcinogeninduced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 82:387-398 (Pubitemid 32729403)
15. Vergote D, Cren-Olive C, Chopin V, Toillon RA, Rolando C, Hondermarck H, Le Bourhis X (2002) (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Res Treat 76:195-201 (Pubitemid 35335209)
16. Gupta S, Ahmad N, Nieminen AL, Mukhtar H (2000) Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgensensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 164:82-90 (Pubitemid 30198547)
17. Lee KW, Kim YJ, Lee HJ, Lee CY (2003) Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem 51:7292-7295
18. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103:1024-1029 (Pubitemid 43212215)
19. Cooper KA, Donovan JL, Waterhouse AL, Williamson G (2008) Cocoa and health: a decade of research. Br J Nutr 99:1-11 (Pubitemid 350286132)
20. Corti R, Flammer AJ, Hollenberg NK, Luscher TF (2009) Cocoa and cardiovascular health. Circulation 119:1433-1441
21. Visioli F, Bernaert H, Corti R, Ferri C, Heptinstall S, Molinari E, Poli A, Serafini M, Smit HJ, Vinson JA, Violi F, Paoletti R (2009) Chocolate, lifestyle, and health. Crit Rev Food Sci Nutr 49:299-312
22. Andrés-Lacueva C, Lamuela-Raventós RM, Jauregui O, Casals I, Izquierdo-Pulido M, Permanyer J (2000) An LC method for the analysis of cocoa phenolics. LCoGC Eur 13:902-904
23. Swain T, Hillis WE (1969) The total phenolic constituents of Prunus domestica. J Sci Food Agric 10:4292-4296
24. Selga E, Morales C, Noe V, Peinado MA, Ciudad CJ (2008) Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells. BMC Med Genomics 1:35
25. Selga E, Oleaga C, Ramirez S, de Almagro MC, Noe V, Ciudad CJ (2009) Networking of differentially expressed genes in human cancer cells resistant to methotrexate. Genome Med 1:83
26. Tapias A, Ciudad CJ, Noe V (2008) Transcriptional regulation of the 5'-flanking region of the human transcription factor Sp3 gene by NF-1, c-Myb, B-Myb, AP-1 and E2F. Biochim Biophys Acta 1779:318-329 (Pubitemid 351645141)
27. Noe V, Alemany C, Chasin LA, Ciudad CJ (1998) Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter. Oncogene 16:1931-1938 (Pubitemid 28200604)
28. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63 (Pubitemid 14203433)
29. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621-681
30. Blasco F, Penuelas S, Cascallo M, Hernandez JL, Alemany C, Masa M, Calbo J, Soler M, Nicolas M, Perez-Torras S, Gomez A, Tarrason G, Noe V, Mazo A, Ciudad CJ, Piulats J (2004) Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy. Oncology 67:277-290 (Pubitemid 39551713)
31. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59:65-85
32. Ciolino HP, Daschner PJ, Yeh GC (1999) Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 340(Pt 3):715-722 (Pubitemid 29312869)
33. Trapani V, Patel V, Leong CO, Ciolino HP, Yeh GC, Hose C, Trepel JB, Stevens MF, Sausville EA, Loaiza-Perez AI (2003) DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br J Cancer 88:599-605 (Pubitemid 36363371)
34. Chisholm K, Bray BJ, Rosengren RJ (2004) Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDAMB-231 human breast cancer cells. Anticancer Drugs 15:889-897 (Pubitemid 39482930)
35. Scandlyn MJ, Stuart EC, Somers-Edgar TJ, Menzies AR, Rosengren RJ (2008) A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. Br J Cancer 99:1056-1063
36. Stuart EC, Larsen L, Rosengren RJ (2007) Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells. Int J Oncol 30:1407-1412
37. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847-23850 (Pubitemid 38725238)
38. Parl FF, Dawling S, Roodi N, Crooke PS (2009) Estrogen metabolism and breast cancer: a risk model. Ann N Y Acad Sci 1155:68-75
39. Huang Z, Fasco MJ, Figge HL, Keyomarsi K, Kaminsky LS (1996) Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab Dispos 24:899-905 (Pubitemid 26274749)
40. Delescluse C, Lemaire G, de Sousa G, Rahmani R (2000) Is CYP1A1 induction always related to AHR signaling pathway? Toxicology 153:73-82
41. Okey AB, Riddick DS, Harper PA (1994) Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol Sci 15:226-232 (Pubitemid 24210727)
42. Ramadass P, Meerarani P, Toborek M, Robertson LW, Hennig B (2003) Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol Sci 76:212-219 (Pubitemid 37361900)
43. Wijayaratne AL, McDonnell DP (2001) The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276:35684-35692
44. Balan KV, Wang Y, Chen SW, Pantazis P, Wyche JH, Han Z (2006) Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition. Biochem Pharmacol 72:566-572 (Pubitemid 44164666)
45. Alarid ET, Bakopoulos N, Solodin N (1999) Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522-1534 (Pubitemid 30650593)
46. Yu KD, Di GH, Li WF, Rao NY, Fan L, Yuan WT, Hu Z, Wu J, Shen ZZ, Huang W, Shao ZM (2010) Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations. Breast Cancer Res Treat 121:157-167
47. Yoshida T, Maeda A, Horinaka M, Shiraishi T, Nakata S, Wakada M, Yogosawa S, Sakai T (2005) Quercetin induces gadd45 expression through a p53-independent pathway. Oncol Rep 14:1299-1303
48. Suganuma M, Saha A, Fujiki H (2011) New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102:317-323
49. Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, Metz J, Kinscherf R (2004) Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 318:325-333 (Pubitemid 39506502)
50. Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, Bentrem DJ, Talamonti MS, Bell RH, Adrian TE (2007) Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res 138:163-169 (Pubitemid 46365718)
51. Lim JH, Park JW, Min DS, Chang JS, Lee YH, Park YB, Choi KS, Kwon TK (2007) NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 12:411-421 (Pubitemid 46169920)
52. Comitato R, Leoni G, Canali R, Ambra R, Nesaretnam K, Virgili F (2010) Tocotrienols activity in MCF-7 breast cancer cells: involvement of ERbeta signal transduction. Mol Nutr Food Res 54:669-678
53. Katz DL, Doughty K, Ali A (2011) Cocoa and chocolate in human health and disease. Antioxid Redox Signal. doi:10.1089/ars.2010.3697
54. Balliet AG, Hollander MC, Fornace AJ Jr, Hoffman B, Liebermann DA (2003) Comparative analysis of the genetic structure and chromosomal mapping of the murine Gadd45g/CR6 gene. DNA Cell Biol 22:457-468 (Pubitemid 36981462)
55. Fletcher N, Wahlstrom D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K, Hellmold H, Hakansson H (2005) 2, 3, 7, 8-Tetrachlorodibenzop-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol Appl Pharmacol 207:1-24 (Pubitemid 41073756)
56. Ferlini C, Scambia G, Distefano M, Filippini P, Isola G, Riva A, Bombardelli E, Fattorossi A, Benedetti Panici P, Mancuso S (1997) Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis. Br J Cancer 75:884-891 (Pubitemid 27110706)
57. Shen F, Xue X, Weber G (1999) Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res 19:1657-1662 (Pubitemid 29392719)
58. McDougal A, Wormke M, Calvin J, Safe S (2001) Tamoxifeninduced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. Cancer Res 61:3902-3907 (Pubitemid 32720948)
59. Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour G, Zhang L, Lu M, Weinberg O, Rao JY, Brooks MN (2006) The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27:2424-2433 (Pubitemid 44884099)
60. Mense SM, Chhabra J, Bhat HK (2008) Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin. J Steroid Biochem Mol Biol 110:157-162